MARY BOYTE: Open Payments
NPI 1750756367 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 18 payments from 13 companies in 2025. Trend: 2023 $984 · 2024 $995 · 2025 $694
Food & beverage: $516Education: $178
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation | 2 | $138 |
| Astellas Pharma Global Development | 1 | $125 |
| Janssen Biotech, Inc. | 3 | $116 |
| Incyte Corporation | 1 | $100 |
| Daiichi Sankyo Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
Products named: RYTELO, Xtandi, RYBREVANT, ENHERTU, LIBTAYO, PADCEV, MONOFERRIC, GIVLAARI.
Industry payments across LA — which companies pay providers there.
